
Encompass Health (EHC) Stock Forecast & Price Target
Encompass Health (EHC) Analyst Ratings
Bulls say
Encompass Health Corp has demonstrated a positive trajectory in its revenue guidance, with the high-end projections for 2024 increasing from $1.065 billion to $1.090 billion, reflecting confidence in its growth outlook. Additionally, the firm's guidance for 2023 also saw an upward revision from $910 million to $950 million, indicating strong operational performance. The company's strategic shift towards a growing Medicare Advantage payer mix, which has risen from approximately 9.2% in 2018 to about 16.5% in 1Q25, further highlights its competitive positioning and supports sustained growth in rehabilitative services.
Bears say
Encompass Health Corp faces significant risks related to its de novo and joint venture strategies, particularly with rising costs associated with facility construction and labor acquisition due to tariff uncertainties and competitive markets. These factors may hinder the company's ability to effectively staff new facilities, which is crucial for achieving mature operating levels. As a result, potential disruptions in staffing could adversely affect the overall earnings profile of the enterprise.
This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.
Encompass Health (EHC) Analyst Forecast & Price Prediction
Start investing in Encompass Health (EHC)
Order type
Buy in
Order amount
Est. shares
0 shares